20.62% | % of shares held by all insiders |
62.17% | % of shares held by institutions |
78.33% | % of float held by institutions |
320 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
QVT Financial LP | 112,541,536 | 30 Dec 2023 | 13.97% | 1,224,451,924 |
SB Investment Advisers (UK) LTD | 73,031,667 | 30 Dec 2023 | 9.06% | 794,584,545 |
Viking Global Investors, L.P. | 69,368,961 | 30 Dec 2023 | 8.61% | 754,734,303 |
FMR, LLC | 36,976,248 | 30 Dec 2023 | 4.59% | 402,301,582 |
Morgan Stanley | 21,927,044 | 30 Dec 2023 | 2.72% | 238,566,241 |
Blackrock Inc. | 20,805,601 | 30 Dec 2023 | 2.58% | 226,364,941 |
Rubric Capital Management LP | 19,000,000 | 30 Dec 2023 | 2.36% | 206,720,002 |
State Street Corporation | 13,727,418 | 30 Dec 2023 | 1.70% | 149,354,309 |
Wellington Management Group, LLP | 13,640,416 | 30 Dec 2023 | 1.69% | 148,407,727 |
Patient Square Capital LP | 12,639,920 | 30 Dec 2023 | 1.57% | 137,522,331 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Fidelity Growth Company Fund | 10,901,291 | 28 Feb 2024 | 1.35% | 118,606,047 |
iShares Core S&P Midcap ETF | 10,506,573 | 30 Mar 2024 | 1.30% | 114,311,515 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 8,584,369 | 28 Feb 2024 | 1.07% | 93,397,935 |
Vanguard Extended Market Index Fund | 4,945,664 | 30 Dec 2023 | 0.61% | 53,808,824 |
Fidelity Select Portfolios - Biotechnology | 4,387,019 | 28 Feb 2024 | 0.54% | 47,730,767 |
Morgan Stanley Inst Fd Inc-Growth Port | 4,130,061 | 30 Dec 2023 | 0.51% | 44,935,064 |
iShares Biotechnology ETF | 4,068,397 | 28 Feb 2024 | 0.50% | 44,264,159 |
Fidelity Growth Company K6 Fund | 3,492,724 | 28 Feb 2024 | 0.43% | 38,000,837 |
Fidelity Series Growth Company Fund | 2,772,000 | 28 Feb 2024 | 0.34% | 30,159,360 |
Fidelity Extended Market Index Fund | 1,863,938 | 28 Feb 2024 | 0.23% | 20,279,645 |